International Journal of Pharmaceutical & Sciences
ISSN: ISSN
1758-2008 (Print )
1758-2016 (Electronic)
International Journal of Pharmaceutical & Sciences

International Journal of Pharmaceutical & Sciences (IJPS) is a peer-reviewed, open-access journal dedicated to publishing high-quality research in pharmaceutical sciences. It serves as a global platform for researchers, academicians, and healthcare professionals to share ground breaking discoveries, innovative methodologies, and critical reviews. The journal aims to bridge the gap between pharmaceutical research and clinical applications, contributing to advancements in drug development, pharmaceutical technology, and patient care.
IJPS covers a broad spectrum of topics, including drug discovery, pharmacology, toxicology, pharmacokinetics, nano medicine, biotechnology, and pharmaceutical formulations. It also explores regulatory affairs, pharmacovigilance, and personalized medicine. The journal emphasizes interdisciplinary collaboration, fostering the integration of cutting-edge scientific research with real-world healthcare applications. By maintaining a rigorous peer-review process, IJPS ensures the publication of impactful studies that drive innovation in pharmaceutical and biomedical sciences.
As an open-access journal, IJPS provides unrestricted access to published content, enhancing the visibility and reach of research findings. It welcomes original research articles, review papers, case studies, and short communications. Through a fast-track publication process, the journal ensures timely dissemination of significant scientific advancements in pharmaceutical sciences.
Drug Discovery and Development
Drug discovery and development is a complex and multi-phase process aimed at identifying, designing, and optimizing pharmaceutical compounds with therapeutic potential. It begins with target identification, where researchers study disease mechanisms to find potential biological targets for drugs. High-throughput screening and computational modeling help identify lead compounds that interact with these targets. Lead optimization follows, improving efficacy, selectivity, and safety. Preclinical testing assesses toxicity and pharmacokinetics in animal models before human trials. The clinical phase involves multiple stages, from small-scale safety trials (Phase I) to large-scale efficacy and safety studies (Phase III). Regulatory approval is sought before the drug reaches the market, ensuring its safety and effectiveness.
Pharmacology and Toxicology
Pharmacology is the study of drug interactions with biological systems, including their mechanisms of action, therapeutic effects, and side effects. It is divided into pharmacodynamics, which examines drug-receptor interactions and physiological responses, and pharmacokinetics, which explores drug absorption, metabolism, and excretion. Toxicology focuses on the adverse effects of drugs and chemicals, assessing their potential risks to human health. It includes acute, chronic, and developmental toxicity studies to determine safe dosage limits. This field is crucial in drug development, ensuring that compounds are not only effective but also safe for human use. Advanced toxicological studies use computational models and alternative testing methods to predict and minimize risks.
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics (PK) and pharmacodynamics (PD) are fundamental in understanding drug behavior within the body. PK studies focus on the absorption, distribution, metabolism, and excretion (ADME) of drugs, determining their bioavailability and half-life. Factors like enzyme activity, transport proteins, and patient-specific metabolism influence drug levels in the bloodstream. PD, on the other hand, examines the biochemical and physiological effects of drugs, including their mechanism of action, receptor binding, and dose-response relationships. Understanding PK/PD relationships helps in optimizing drug dosing, reducing toxicity, and enhancing therapeutic efficacy. This field is essential in precision medicine, ensuring individualized treatment approaches for better patient outcomes.
Nanomedicine and Drug Delivery
Nanomedicine applies nanotechnology to enhance drug delivery, imaging, and therapy. It involves using nanoparticles, liposomes, and polymer-based carriers to improve drug solubility, stability, and bioavailability. Targeted drug delivery systems ensure drugs reach specific tissues or cells, minimizing side effects and increasing therapeutic efficacy. Innovations like stimuli-responsive nanoparticles release drugs in response to specific triggers such as pH changes or enzymes in diseased tissues. Nanomedicine also plays a role in cancer therapy, where nanoparticles deliver chemotherapeutic agents directly to tumors, reducing systemic toxicity. Additionally, it facilitates gene therapy, antimicrobial treatments, and vaccine development, transforming modern medicine through more efficient and personalized therapeutic options.
Biopharmaceutics and Biotechnology
Biopharmaceutics studies how the physical, chemical, and biological properties of drugs influence their absorption and bioavailability. It focuses on drug formulation and the impact of factors like solubility and dissolution rate on therapeutic efficacy. Biotechnology plays a significant role in drug development by using genetic engineering, recombinant DNA technology, and monoclonal antibodies to create advanced biologics. These include gene therapies, vaccines, and protein-based drugs like insulin and monoclonal antibodies for cancer treatment. The integration of biopharmaceutics and biotechnology has led to innovations in targeted drug therapies, biosimilars, and regenerative medicine, improving treatment options for complex diseases such as autoimmune disorders and genetic conditions.
Regulatory Affairs and Pharmacovigilance
Regulatory affairs ensure that pharmaceutical products meet legal and safety standards before entering the market. Regulatory agencies like the FDA, EMA, and WHO set guidelines for drug approval, requiring extensive clinical trial data to confirm efficacy and safety. Post-marketing surveillance, or pharmacovigilance, monitors drugs after they reach consumers, identifying adverse effects and ensuring continued patient safety. Reports of side effects, drug interactions, and long-term risks are collected through databases like the FDA Adverse Event Reporting System. Regulatory professionals also oversee compliance with Good Manufacturing Practices (GMP) and Good Clinical Practices (GCP), ensuring ethical and scientific integrity in pharmaceutical research and production.
Personalized and Precision Medicine
Personalized medicine tailors treatments to individual patients based on genetic, molecular, and environmental factors. Unlike conventional one-size-fits-all approaches, precision medicine uses biomarkers, pharmacogenomics, and advanced diagnostics to customize drug therapy. Genetic testing can predict drug responses, guiding clinicians in selecting the most effective medications while minimizing side effects. For example, cancer treatments like targeted therapy drugs (e.g., HER2 inhibitors for breast cancer) work only for patients with specific genetic mutations. The rise of AI-driven data analysis and wearable health monitoring devices is further enhancing personalized medicine, leading to more accurate diagnoses, better treatment strategies, and improved patient outcomes.
Clinical and Translational Research
Clinical and translational research bridges laboratory discoveries with practical medical applications, ensuring that scientific innovations reach patients efficiently. Translational medicine, often described as “bench to bedside,” focuses on applying preclinical research findings to develop new diagnostics, treatments, and medical devices. Clinical research involves human trials assessing drug efficacy and safety through different phases. Challenges in this field include patient recruitment, ethical considerations, and data reliability. Advances such as AI-driven analytics and digital health records are improving trial efficiency. By accelerating the transition from basic science to clinical practice, translational research enhances patient care and fosters continuous medical innovation.
Formulation Science and Pharmaceutical Technology
Formulation science focuses on designing and optimizing pharmaceutical dosage forms, including tablets, capsules, injectables, and controlled-release formulations. It ensures drug stability, bioavailability, and patient compliance. Advances in pharmaceutical technology, such as 3D printing of personalized drug doses and nanocarriers for targeted delivery, are transforming drug manufacturing. Excipients play a critical role in formulation, affecting drug release rates and stability. Research in this field also explores alternative drug delivery methods, such as transdermal patches and inhalable therapies. The goal is to improve therapeutic efficacy, minimize side effects, and enhance patient adherence through innovative drug formulations and technologies.
Herbal and Natural Medicine
Herbal and natural medicine explores plant-based remedies, traditional healing practices, and alternative medicinal products. Many modern drugs originate from plant compounds, such as aspirin from willow bark and paclitaxel from the Pacific yew tree. Research in this field investigates bioactive compounds, their pharmacological effects, and safety profiles. Standardization, quality control, and clinical validation are essential to integrating herbal medicine into mainstream healthcare. Ethnopharmacology studies indigenous medicinal knowledge, contributing to drug discovery. Advances in biotechnology are enhancing the extraction and synthesis of herbal compounds, ensuring consistency and efficacy. Herbal medicine remains a valuable complementary approach in treating various health conditions.




